Literature DB >> 17145832

In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model.

Borbala Daroczi1, Gabor Kari, Mary Frances McAleer, Jeffrey C Wolf, Ulrich Rodeck, Adam P Dicker.   

Abstract

PURPOSE: We have previously shown that zebrafish (Danio rerio) embryos can be used as an in vivo model to validate modifiers of the radiation response. Here, we evaluated the radioprotective effect of the nanoparticle DF-1, a fullerene with antioxidant properties, in zebrafish embryos. EXPERIMENTAL
DESIGN: Zebrafish embryos were exposed to different doses of ionizing radiation ranging from 20 to 80 Gy in the presence and absence of DF-1. Toxicity and radioprotective effects were assessed by monitoring overall survival and morphology as well as organ functions by employing assays to measure kidney excretory function and development of sensory nerve cells (neuromasts). Antioxidant properties of DF-1 were assessed in whole fish.
RESULTS: DF-1 had no apparent adverse effects on normal zebrafish morphology or viability throughout the concentration range tested (1-1,000 micromol/L). Ionizing radiation (10-40 Gy) caused time-dependent and dose-dependent perturbations of normal zebrafish morphology and physiology, notably defective midline development resulting in dorsal curvature of the body axis ("curly-up"), neurotoxicity, impaired excretory function, and decreased survival of the exposed embryos. DF-1 (100 micromol/L) markedly attenuated overall and organ-specific radiation-induced toxicity when given within 3 hours before or up to 15 minutes after radiation exposure. By contrast, DF-1 afforded no protection when given 30 minutes after ionizing radiation. The degree of radioprotection provided by DF-1 was comparable with that provided by the Food and Drug Administration-approved radioprotector amifostine (4 mmol/L). Protection against radiation-associated toxicity using DF-1 in zebrafish embryos was associated with marked reduction of radiation-induced reactive oxygen species.
CONCLUSION: The fullerene DF-1 protects zebrafish embryos against deleterious effects of ionizing radiation due, in part, to its antioxidant properties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17145832     DOI: 10.1158/1078-0432.CCR-06-0514

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  27 in total

1.  Radiation protection of the gastrointestinal tract and growth inhibition of prostate cancer xenografts by a single compound.

Authors:  Vitali Alexeev; Elizabeth Lash; April Aguillard; Laura Corsini; Avi Bitterman; Keith Ward; Adam P Dicker; Alban Linnenbach; Ulrich Rodeck
Journal:  Mol Cancer Ther       Date:  2014-11-14       Impact factor: 6.261

2.  Alpha radiation exposure decreases apoptotic cells in zebrafish embryos subsequently exposed to the chemical stressor, Cd.

Authors:  K N Yu; M M T Tung; V W Y Choi; S H Cheng
Journal:  Environ Sci Pollut Res Int       Date:  2012-06-20       Impact factor: 4.223

Review 3.  Beyond nC60: strategies for identification of transformation products of fullerene oxidation in aquatic and biological samples.

Authors:  Benny F G Pycke; Tzu-Chiao Chao; Pierre Herckes; Paul Westerhoff; Rolf U Halden
Journal:  Anal Bioanal Chem       Date:  2012-05-28       Impact factor: 4.142

4.  Internalization of C60 fullerenes into cancer cells with accumulation in the nucleus via the nuclear pore complex.

Authors:  Mustafa Raoof; Yuri Mackeyev; Matthew A Cheney; Lon J Wilson; Steven A Curley
Journal:  Biomaterials       Date:  2012-01-14       Impact factor: 12.479

5.  Convergence of nanotechnology with radiation therapy-insights and implications for clinical translation.

Authors:  Dev Kumar Chatterjee; Tatiana Wolfe; Jihyoun Lee; Aaron P Brown; Pankaj Kumar Singh; Shanta Raj Bhattarai; Parmeswaran Diagaradjane; Sunil Krishnan
Journal:  Transl Cancer Res       Date:  2013-08-23       Impact factor: 1.241

Review 6.  Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Drug Discov Today       Date:  2012-08-10       Impact factor: 7.851

7.  Evaluation of the fullerene compound DF-1 as a radiation protector.

Authors:  Aaron P Brown; Eun Joo Chung; Mary Ellen Urick; William P Shield; Anastasia L Sowers; Angela Thetford; Uma T Shankavaram; James B Mitchell; Deborah E Citrin
Journal:  Radiat Oncol       Date:  2010-05-11       Impact factor: 3.481

Review 8.  Biomedical applications of functionalized fullerene-based nanomaterials.

Authors:  Ranga Partha; Jodie L Conyers
Journal:  Int J Nanomedicine       Date:  2009

9.  Differential regulation of p53 function by the N-terminal ΔNp53 and Δ113p53 isoforms in zebrafish embryos.

Authors:  William R Davidson; Csaba Kari; Qing Ren; Borbala Daroczi; Adam P Dicker; Ulrich Rodeck
Journal:  BMC Dev Biol       Date:  2010-10-07       Impact factor: 1.978

Review 10.  SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Emily R H Roberts; Zeljko Vujaskovic; Kam W Leong; Ivan Spasojevic
Journal:  Antioxid Redox Signal       Date:  2013-10-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.